ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1127

The Pathogenetic Role of Calcium Pyrophosphate and Basic Calcium Phosphate Crystals in Osteoarthritis: Associations with Synovial Fluid Cytokines and Clinical Indices

Francesca Oliviero1, Chiara Baggio2, Amelia Damasco2, Federico Zorzi3, Mariagrazia Lorenzin2, Giacomo Cozzi2 and Roberta Ramonda4, 1Rheumatology Unit, Department od Medicine - DIMED, University of Padova, Padova, Veneto, Italy, 2Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Veneto, Italy, 3Center for Analysis and Certification Services (CEASC), University of Padova, Padova, Veneto, Italy, 4Rheumatology Unit-DIMED-University of Padova ITALY, Padova, Padua, Italy

Meeting: ACR Convergence 2025

Keywords: chemokines, Inflammation, Metabolic Crystal, Osteoarthritis, WOMAC

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1123–1146) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Calcium pyrophosphate (CPP) and basic calcium phosphate (BCP) crystals are frequent features of synovial fluid (SF) in patients with osteoarthritis (OA). Although these crystals have shown pro-inflammatory properties in vitro, their pathogenetic role is not completely clear. Our previous studies demonstrated that the presence of CPP in SF is associated with a mild inflammatory status and more advanced stages of the disease (Oliviero F, 2023; Frallonardo P, 2018). With this study we aimed to investigate SF cytokines and clinical indices of disease in a cohort of OA patients with or without CPP and BCP in their SF.

Methods: SF samples were collected from 40 patients with OA attending our outpatient clinic and analyzed as part of routine procedures. Patients were asked to complete the WOMAC and Lequesne questionnaires and a VAS scale for pain. OA severity was classified according to the Kellgren and Lawrence system. Total leucocytes, differential cell count and crystal search were performed in all the samples. CPP crystals were identified by polarized light microscopy (PLM) while BCP were assessed by Environmental Scanning Electron Microscopy (ESEM) and energy-dispersive X-ray (EDX) spectra, after samples centrifugation. Discarded SFs were stored for cytokine (IL-1, IL-18, IL-8, CCL23) determinations.

Results: ESEM analysis confirmed the presence of CPP in all SF positive at the PLM (n. 14) and in no additional samples. BCP have been found in 13 specimens, 7 of which were also positive to CPP. Given the low number of BCP+ SFs, we firstly compared the CPP+ and the CPP- groups. Patients with CPP showed higher WOMAC (p=0.04) and VAS pain (0.039). Although non-significant, IL-8 and CCL23 were higher in CPP+ samples. Examining data according to ESEM results, we found a significant distribution of CPP in the group of patients with a KL=3-4 and BCP in the group KL=1-2 (p=0.025) (Fig.1). Patients positive for both CPP and BCP had the worse clinical indices (WOMAC and pain 0.04). The levels of CLL23, which we demonstrated to be highly induced in vitro by CPP crystals (Baggio C, 2025), are similar in the groups CPP+ and CPP+BCP+, and decrease in the group BCP+, CPP-BCP-. IL-8 was higher in the group positive to both crystals but lower in the BCP+ group.

Conclusion: This study supports the concept that calcium crystals are not mere bystanders in OA, but rather play a pathogenetic role. CCL23 emerges as a new chemokine that warrants further exploration in OA research.

Supporting image 1


Disclosures: F. Oliviero: None; C. Baggio: None; A. Damasco: None; F. Zorzi: None; M. Lorenzin: None; G. Cozzi: None; R. Ramonda: None.

To cite this abstract in AMA style:

Oliviero F, Baggio C, Damasco A, Zorzi F, Lorenzin M, Cozzi G, Ramonda R. The Pathogenetic Role of Calcium Pyrophosphate and Basic Calcium Phosphate Crystals in Osteoarthritis: Associations with Synovial Fluid Cytokines and Clinical Indices [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-pathogenetic-role-of-calcium-pyrophosphate-and-basic-calcium-phosphate-crystals-in-osteoarthritis-associations-with-synovial-fluid-cytokines-and-clinical-indices/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-pathogenetic-role-of-calcium-pyrophosphate-and-basic-calcium-phosphate-crystals-in-osteoarthritis-associations-with-synovial-fluid-cytokines-and-clinical-indices/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology